RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Imaging Powerhouse | RadNet's market dominance in outpatient diagnostic imaging services, with a $4.2 billion market cap, showcases its pivotal role in the US healthcare landscape |
Strategic Expansion | Delve into RadNet's acquisition of iCAD for $103 million, a move set to bolster its DeepHealth segment and expand its technological capabilities |
Resilient Performance | Explore how RadNet navigated operational challenges to exceed revenue expectations, raising guidance despite severe weather impacts on operations |
Future Trajectory | Learn about RadNet's path to accelerated growth in 2026-2027, with analysts setting a price target of $60, reflecting optimism in the company's strategic initiatives |
Metrics to compare | RDNT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRDNTPeersSector | |
---|---|---|---|---|
P/E Ratio | −364.0x | −19.4x | −0.7x | |
PEG Ratio | 1.49 | 0.11 | 0.00 | |
Price/Book | 5.8x | 1.3x | 2.6x | |
Price / LTM Sales | 2.8x | 1.5x | 3.4x | |
Upside (Analyst Target) | 11.9% | 66.0% | 38.0% | |
Fair Value Upside | Unlock | 22.5% | 5.2% | Unlock |